Evidence map›Paper›PMID 21792529›Full record

ReviewWiener medizinische Wochenschrift (1946)2011

[Psychotropic drugs and diabetes].

Claudia Ress, Alexander Tschoner, Susanne Kaser, Christoph F Ebenbichler

Abstract readReview
PubMed Publisher
In one paragraph

Review in Wiener medizinische Wochenschrift (1946), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. [Mental disorders and diabetes mellitus (Update 2023)].Wiener klinische Wochenschrift · 2023
    Article
  4. [Mental disorders and diabetes mellitus (Update 2019)].Wiener klinische Wochenschrift · 2019
    Review
  5. [Mental disorders and diabetes mellitus].Wiener klinische Wochenschrift · 2016
    Review
  6. [Mental disorders and diabetes mellitus].Wiener klinische Wochenschrift · 2012
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Claudia RessDepartment für Innere Medizin I, Medizinische Universität Innsbruck, Austria.
Alexander Tschoner
Susanne Kaser
Christoph F Ebenbichler
Innsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychotropic drugs, such as antipsychotics and antidepressants, are widely used substances which can display marked metabolic side effects. Psychiatric patients display increased morbidity and mortality which, besides disease specific factors, may be attributed to metabolic side effects of psychotropic drugs. Commonly observed side effects of antipsychotics are weight gain as well as disturbances in glucose and lipid metabolism. Additionally, antipsychotics have been shown to increase diabetes risk. Also, the use of some of the antidepressant substances is associated with an increased diabetes risk. However, large inter-substance variations have been observed. Conversely, diabetics have an increased risk of depression. Metabolic side effects of psychotropic drugs pose a serious impairment for psychiatric patients and their management can play a pivotal role in therapeutic compliance and success. This review aims to give an overview of metabolic side effects of commonly used psychotic drugs and to give an insight into possible underlying mechanisms.

Indexed as

Antidepressive AgentsAntipsychotic AgentsDepressive DisorderDiabetes Mellitus, Type 2HumansMedication AdherenceMetabolic SyndromeObesityPsychotic DisordersRiskWeight GainAntidepressive AgentsAntipsychotic Agents

Identifiers

PMID21792529
OpenAlexW203784763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.